TACE联合微波消融治疗膈下肝癌的疗效及安全性研究
2020-12-23郑磊王晓建薄进保
郑磊 王晓建 薄进保

[摘要] 目的 探讨TACE(经导管动脉化疗栓塞术)联合微波消融治疗膈下肝癌的临床效果。方法 方便择取2017年7月—2019年9月该院40例膈下肝癌患者,随机分为两组。治疗组23例,予以TACE联合微波消融治疗;对照组17例,予以单纯TACE治疗。术后影像学复查,观察病灶变化,随访评价两组疗效,统计并发症。结果 两组TACE术后均可见碘油沉积,治疗组完全微波消融率91.30%。术后随访,治疗组治疗有效率(86.96%)高于对照组(64.71%),疾病控制率(95.65%)高于对照组(82.35%),差异有统计学意义(χ2=5.326、4.457,P<0.05)。治疗组术后并发症(4.35%)与对照组(0.00%)差异无统计学意义(χ2=2.107,P>0.05)。 结论 TACE联合微波消融治疗膈下肝癌效果优于单纯TACE治疗,且不明显增加并发症,安全性理想。
[关键词] 膈下肝癌;TACE;微波消融;疗效;安全性
[中图分类号] R735 [文献标识码] A [文章编号] 1674-0742(2020)06(b)-0041-03
[Abstract] Objective To explore the clinical effect of TACE (transcatheter arterial chemoembolization) combined with microwave ablation in the treatment of subphrenic liver cancer. Methods From July 2017 to September 2019, 40 patients with subphrenic liver cancer in the hospital were convenienty selected and randomly divided into two groups. 23 cases in the treatment group were treated with TACE combined with microwave ablation; 17 cases in the control group were treated with TACE alone. Postoperative imaging review, observation of lesion changes, follow-up evaluation of the efficacy of the two groups, statistical complications. Results Iodine oil deposits were seen after TACE in both groups, and the complete microwave ablation rate in the treatment group was 91.30%. After the follow-up, the treatment group's effective rate (86.96%) was higher than that of the treatment group (64.71%), and the disease control rate (95.65%) was higher than that of the treatment group(82.35%),the difference was statistically significant(χ2=5.326,4.457,P<0.05). Postoperative complications (4.35%) in the treatment group were not statistically significantly different from those in the control group (0.00%)(χ2= 2.107, P>0.05). Conclusion TACE combined with microwave ablation is better than TACE alone in the treatment of subphrenic liver cancer, and there is no significant increase in complications, with ideal safety.
[Key words] Subphrenic liver cancer; TACE; Microwave ablation; Efficacy; Safety
肝癌是臨床常见恶性肿瘤,流行病学统计全球每年发病约26万,其中我国占比超过40%[1],国家癌症中心2018调研数据显示,发病率分别居我国男性第2位和女性第3位[2],是威胁国民生命健康的严重疾病问题。该病的发生与病毒性肝炎、饮酒、食用霉变食物等因素有关,临床治疗以手术为首选,但由于起病隐匿,早期缺乏典型征象,或合并肝硬化,肝功能差,导致很多肝癌患者确诊时已丧失外科手术治疗时机[3]。介入手术是基于医学影像设备引导,将特制精密仪器等引入人体进行疾病局部诊治的医疗技术,具有精确治疗、创伤小、不良反应少、康复快的治疗优势[4],近年广泛应用于临床。其中,TACE与微波消融对于已经错失手术时机的肝癌患者而言,是理想的治疗方式,在控制肿瘤进展方面收效理想,但对于治疗毗邻膈肌、心、肺等重要脏器的膈下肝癌,治疗难度较高,且存在一定风险[5],临床报道较少。……
